A phase III randomized, controlled trial of nedaplatin versus cisplatin concurrent chemoradiotherapy in patients with cervical cancer

BACKGROUND: We evaluated the non-inferiority of nedaplatin-based and cisplatin-based concurrent chemoradiotherapy in cervical cancer patients. DESIGN: Patients aged 28-82 years with pathologically diagnosed cervical cancer (stage IB-IVA) were randomly chosen for the study. Patients in both the cispl...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, X., Ren, H., Li, Z., Zhang, L., Shao, Y., Li, H., Sun, Y., Zhang, X., Wang, Z., Fu, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588898/
https://www.ncbi.nlm.nih.gov/pubmed/35994789
http://dx.doi.org/10.1016/j.esmoop.2022.100565

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588898/
https://www.ncbi.nlm.nih.gov/pubmed/35994789
http://dx.doi.org/10.1016/j.esmoop.2022.100565

Ejemplares similares